文献速递脊柱关节炎

明确目标:中轴型脊柱关节炎的临床治疗目标

Defining the target: clinical aims in axial spondyloarthritis.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

本文探讨达标治疗(T2T)在中轴型脊柱关节炎(axSpA)临床实践中的可行性。2016年ASAS/EULAR指南推荐按预设目标指导治疗,但目标定义仍有争议;国际工作组推荐以缓解或非活动性疾病为目标。文章还讨论ASDAS等复合结局指标的应用及不同治疗策略的有效性。

要点

  • 2016年ASAS/EULAR指南推荐axSpA治疗应按预设目标进行。
  • 国际工作组推荐以缓解或非活动性疾病作为期望结局。
  • 有限证据提示应在疾病早期、骨修复过程开始前启动治疗。

核心结论

  • T2T是axSpA新兴治疗范式,目标为缓解或低疾病活动度以最大化生活质量。
  • 国际工作组推荐缓解或非活动性疾病为期望结局,但最佳结局测量工具仍存争议。
  • 有限证据提示应在疾病早期、骨修复开始前启动治疗,T2T成功可能更依赖治疗策略而非单个疗法。

研究设计与样本

  • 本文为综述,探讨T2T在axSpA临床实践中的可行性、ASDAS等复合结局指标的应用及不同治疗策略的有效性。

主要发现

  • 2016年ASAS/EULAR axSpA指南更新推荐治疗应按预设目标指导,但目标定义仍有争议。
  • 国际工作组推荐缓解或非活动性疾病为期望结局,但多种结局测量工具中哪个最合适仍不明确。
  • 有限证据提示应在疾病早期、炎症期后预期骨修复过程开始前启动治疗。
  • 有观点认为T2T范式的成功可能更依赖治疗策略而非所用单个疗法。

关键数值与推荐

  • 2016年ASAS/EULAR axSpA指南推荐治疗应按预设目标指导。
  • 国际工作组推荐以缓解或非活动性疾病作为期望结局。

临床怎么用

  • 在axSpA临床实践中可考虑按预设目标(缓解或非活动性疾病)指导治疗。
  • 可应用ASDAS等复合疾病活动度结局指标进行目标评估。
  • 有限证据提示应在疾病早期、骨修复过程开始前启动治疗。

局限性

  • axSpA中T2T的目标定义仍有争议,最佳结局测量工具尚不明确。
  • 关于何时干预的证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Treat-to-target (T2T) is an emerging treatment paradigm in axial spondyloarthritis (axSpA), originally based on evidence from other inflammatory conditions, which aims to direct therapy to a clear target such as disease remission or low disease activity, with the ultimate goal of maximizing quality of life in affected individuals. The 2016 update of the Assessment of Spondyloarthritis International Society/EULAR guidelines for axSpA have recommended that treatment should be guided according to a predefined target but controversy remains as to what this target should be. An international task force has recommended remission or inactive disease as the desired outcome; however, there are many disease outcome measures developed for use in clinical practice in axSpA and the question remains of which is the most appropriate to use. Another important consideration when discussing the T2T paradigm is when to intervene. Although evidence is limited in this respect, the available data suggest that therapy should be commenced at an early stage of the disease, when the process of bone repair expected to occur after an inflammatory phase has not yet started. It has also been argued that the success of the T2T paradigm may depend more on the treatment strategy than the individual therapies utilized. This article will explore the feasibility of using a T2T approach in axSpA clinical practice, the utilization of new composite outcome measures of disease activity such as the ASDAS, and the validity of different treatment strategies to allow for a T2T intervention in these patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Marzo-Ortega H, Gaffney KM, Gaffney K, et al. Defining the target: clinical aims in axial spondyloarthritis. Rheumatology (Oxford). 2018. PMID: 30445481. doi:10.1093/rheumatology/key176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。